Search Results for: Schizophrenia

1632 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
AMBP and ENO1 alpha-1-microglobulin/bikunin precursor enolase 1, (alpha)
  • Scavenging of heme from plasma
  • Gluconeogenesis
  • Glucose metabolism
  • Myoclonic epilepsy of Lafora
  • Glycogen storage diseases
  • Glycolysis
  • Metabolism of carbohydrates
  • Human Serum Albumin
  • Serum albumin iodonated
AMFR and BAG6 autocrine motility factor receptor, E3 ubiquitin protein ligase BCL2-associated athanogene 6
BIN1 and RIN2 bridging integrator 1 Ras and Rab interactor 2
ANK3 and HOOK1 ankyrin 3, node of Ranvier (ankyrin G) hook microtubule-tethering protein 1
  • Interaction between L1 and Ankyrins
  • Axon guidance
  • L1CAM interactions
ANK3 and KCNC1 ankyrin 3, node of Ranvier (ankyrin G) potassium channel, voltage gated Shaw related subfamily C, member 1
  • Interaction between L1 and Ankyrins
  • Axon guidance
  • L1CAM interactions
  • Potassium Channels
  • Voltage gated Potassium channels
ANK3 and SPTBN4 ankyrin 3, node of Ranvier (ankyrin G) spectrin, beta, non-erythrocytic 4
  • Interaction between L1 and Ankyrins
  • Axon guidance
  • L1CAM interactions
  • Interaction between L1 and Ankyrins
  • Axon guidance
  • L1CAM interactions
  • NCAM signaling for neurite out-growth
ANK3 and FADD ankyrin 3, node of Ranvier (ankyrin G) Fas (TNFRSF6)-associated via death domain
  • Interaction between L1 and Ankyrins
  • Axon guidance
  • L1CAM interactions
  • Regulation by c-FLIP
  • Caspase-8 activation by cleavage
  • Death Receptor Signalling
  • Dimerization of procaspase-8
  • TRAIL signaling
  • TRIF-mediated TLR3/TLR4 signaling
  • FasL/ CD95L signaling
  • MyD88-independent cascade
  • Activated TLR4 signalling
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 3 (TLR3) Cascade
  • Toll Like Receptor 4 (TLR4) Cascade
  • Programmed Cell Death
  • NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
  • TRIF-mediated programmed cell death
  • Extrinsic Pathway
  • Innate Immune System
ANK3 and SCNN1B ankyrin 3, node of Ranvier (ankyrin G) sodium channel, non voltage gated 1 beta subunit
  • Interaction between L1 and Ankyrins
  • Axon guidance
  • L1CAM interactions
  • Ion channel transport
  • Stimuli-sensing channels
  • Triamterene
  • Amiloride
ANK3 and SMAD2 ankyrin 3, node of Ranvier (ankyrin G) SMAD family member 2
  • Interaction between L1 and Ankyrins
  • Axon guidance
  • L1CAM interactions
  • Loss of Function of TGFBR2 in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Downregulation of TGF-beta receptor signaling
  • TGF-beta receptor signaling activates SMADs
  • TGFBR1 LBD Mutants in Cancer
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Generic Transcription Pathway
  • Signaling by NODAL
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by Activin
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • Loss of Function of TGFBR1 in Cancer
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • SMAD4 MH2 Domain Mutants in Cancer
ANK3 and SMAD3 ankyrin 3, node of Ranvier (ankyrin G) SMAD family member 3
  • Interaction between L1 and Ankyrins
  • Axon guidance
  • L1CAM interactions
  • Loss of Function of TGFBR2 in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Downregulation of TGF-beta receptor signaling
  • TGF-beta receptor signaling activates SMADs
  • TGFBR1 LBD Mutants in Cancer
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Generic Transcription Pathway
  • Signaling by NODAL
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by Activin
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • Loss of Function of TGFBR1 in Cancer
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • SMAD4 MH2 Domain Mutants in Cancer
ANK3 and FAS ankyrin 3, node of Ranvier (ankyrin G) Fas cell surface death receptor
  • Interaction between L1 and Ankyrins
  • Axon guidance
  • L1CAM interactions
  • Death Receptor Signalling
  • FasL/ CD95L signaling
  • Programmed Cell Death
  • Extrinsic Pathway
ANK3 and SCN2A ankyrin 3, node of Ranvier (ankyrin G) sodium channel, voltage gated, type II alpha subunit
  • Interaction between L1 and Ankyrins
  • Axon guidance
  • L1CAM interactions
  • Interaction between L1 and Ankyrins
  • Axon guidance
  • L1CAM interactions
ANK3 and SCN1B ankyrin 3, node of Ranvier (ankyrin G) sodium channel, voltage gated, type I beta subunit
  • Interaction between L1 and Ankyrins
  • Axon guidance
  • L1CAM interactions
  • Interaction between L1 and Ankyrins
  • Axon guidance
  • L1CAM interactions
ANK3 and PIK3R1 ankyrin 3, node of Ranvier (ankyrin G) phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
  • Interaction between L1 and Ankyrins
  • Axon guidance
  • L1CAM interactions
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Metabolism of lipids and lipoproteins
  • Signaling by FGFR in disease
  • Signaling by EGFRvIII in Cancer
  • Signaling by SCF-KIT
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • PI3K/AKT activation
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Interleukin receptor SHC signaling
  • PI-3K cascade
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Signaling by FGFR1 mutants
  • Interleukin-7 signaling
  • Role of phospholipids in phagocytosis
  • Phospholipid metabolism
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • PI3K Cascade
  • Signaling by PDGF
  • DAP12 interactions
  • GAB1 signalosome
  • G-protein beta:gamma signalling
  • CD28 co-stimulation
  • CD28 dependent PI3K/Akt signaling
  • Signaling by ERBB4
  • Constitutive PI3K/AKT Signaling in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • PI3K events in ERBB4 signaling
  • G alpha (q) signalling events
  • Signaling by ERBB2
  • Signaling by EGFR
  • GPCR downstream signaling
  • Signaling by Interleukins
  • TCR signaling
  • Signaling by VEGF
  • GP1b-IX-V activation signalling
  • Downstream signal transduction
  • Signaling by FGFR mutants
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Nephrin interactions
  • Interleukin-2 signaling
  • PI3K/AKT Signaling in Cancer
  • Platelet activation, signaling and aggregation
  • Interleukin-3, 5 and GM-CSF signaling
  • Adaptive Immune System
  • G alpha (q) signalling events
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • IRS-mediated signalling
  • PIP3 activates AKT signaling
  • IGF1R signaling cascade
  • VEGFA-VEGFR2 Pathway
  • Synthesis of PIPs at the plasma membrane
  • IRS-related events triggered by IGF1R
  • G beta:gamma signalling through PI3Kgamma
  • PI3K events in ERBB2 signaling
  • Regulation of signaling by CBL
  • Downstream signaling of activated FGFR
  • G alpha (12/13) signalling events
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • PI Metabolism
  • Innate Immune System
  • Signaling by Insulin receptor
  • Signalling by NGF
  • Insulin receptor signalling cascade
  • Cytokine Signaling in Immune system
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • IRS-related events
  • NGF signalling via TRKA from the plasma membrane
  • Tie2 Signaling
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Cell surface interactions at the vascular wall
  • Signaling by FGFR
  • IRS-mediated signalling
  • Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
  • GPVI-mediated activation cascade
  • Interleukin receptor SHC signaling
  • Signaling by FGFR1 fusion mutants
  • Constitutive Signaling by EGFRvIII
  • PI3K Cascade
  • Isoproterenol
  • (1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE
ANK3 and MAPK6 ankyrin 3, node of Ranvier (ankyrin G) mitogen-activated protein kinase 6
  • Interaction between L1 and Ankyrins
  • Axon guidance
  • L1CAM interactions
ANXA1 and UNC119 annexin A1 unc-119 homolog (C. elegans)
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
ANXA1 and S100A11 annexin A1 S100 calcium binding protein A11
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
ANXA1 and TGM2 annexin A1 transglutaminase 2
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
  • Guanosine-5\'-Diphosphate
ANXA1 and KRT8 annexin A1 keratin 8, type II
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
ANXA1 and UBE2D1 annexin A1 ubiquitin-conjugating enzyme E2D 1
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Loss of Function of TGFBR2 in Cancer
  • Phosphorylation of the APC/C
  • Negative regulators of RIG-I/MDA5 signaling
  • Cellular Senescence
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • APC/C:Cdc20 mediated degradation of Securin
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • Signaling by BMP
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Generic Transcription Pathway
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • TRIF-mediated TLR3/TLR4 signaling
  • Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase
  • Loss of Function of SMAD4 in Cancer
  • Senescence-Associated Secretory Phenotype (SASP)
  • TGFBR1 KD Mutants in Cancer
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • Regulation of APC/C activators between G1/S and early anaphase
  • APC/C-mediated degradation of cell cycle proteins
  • APC/C:Cdc20 mediated degradation of Cyclin B
  • Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components
  • Toll Like Receptor 3 (TLR3) Cascade
  • Toll Like Receptor 4 (TLR4) Cascade
  • Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
  • APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
  • Mitotic Metaphase and Anaphase
  • Adaptive Immune System
  • Cellular response to hypoxia
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Regulation of Hypoxia-inducible Factor (HIF) by oxygen
  • Separation of Sister Chromatids
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Inactivation of APC/C via direct inhibition of the APC/C complex
  • Mitotic Anaphase
  • TGFBR1 LBD Mutants in Cancer
  • M Phase
  • Inactivation of APC/C via direct inhibition of the APC/C complex
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • Mitotic Spindle Checkpoint
  • Activated TLR4 signalling
  • Class I MHC mediated antigen processing & presentation
  • Innate Immune System
  • Loss of Function of SMAD2/3 in Cancer
  • IKK complex recruitment mediated by RIP1
  • TGFBR2 Kinase Domain Mutants in Cancer
  • MyD88-independent cascade
  • Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
  • Toll-Like Receptors Cascades
  • Signaling by TGF-beta Receptor Complex
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Regulation of mitotic cell cycle
  • Cell Cycle Checkpoints
  • SMAD4 MH2 Domain Mutants in Cancer
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone

Page 3 out of 82 pages